Cite
HARVARD Citation
Booty, M. et al. (n.d.). 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants. Journal for immunotherapy of cancer. p. A86. [Online].